Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open-label, Controlled, Parallel, Multicenter Study in Kidney Failure Patients on Hemodialysis Comparing the Theranova Dialyzer to Hemodiafiltration

NCT05309291 is registered in ClinicalTrials.gov with Vantive Health LLC as lead sponsor.

NCT NCT05309291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05309291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open-label, Controlled, Parallel, Multicenter Study in Kidney Failure Patients on Hemodialysis Comparing the Theranova Dialyzer to Hemodiafiltration
Lead sponsor
Vantive Health LLC
Phase
Not applicable
Overall status
Completed
Start date
June 22, 2022
Completion date
July 6, 2023
Enrollment
323 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney failure, chronic kidney failure